Business · 08/12/2022Updated: 10/17/2026 · 1 min read
Teva Branded Pharmaceutical Products R and D, Inc., et al.; Withdrawal of Approval of 35 New Drug Applications
Summary
The Food and Drug Administration (FDA) has withdrawn the approval of 35 new drug applications from multiple pharmaceutical companies, including Teva Branded Pharmaceutical Products R and D, Inc., following written notifications that the drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →